Niki BioSolutions, Inc. (NIKI) Research & Development (2017 - 2025)
Niki BioSolutions' (NIKI) quarterly Research & Development came in at $529907.0 in Q4 2025, up 148.57% YoY from $213186.0 in Q4 2024, and up 259.19% on a QoQ basis from -$332878.0 in Q3 2025.
Niki BioSolutions, Inc. (NIKI) Research & Development (2017 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 6 years of Research & Development data on file, last reported at $529907.0 in Q4 2025.
- Quarterly Research & Development rose 148.57% year-over-year to $529907.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $598237.0 (changed N/A YoY) and the FY2025 annual result came in at -$352879.0, up 83.92% from the prior year.
- Research & Development grew to $529907.0 in Q4 2025, from -$332878.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $529907.0 in Q4 2025 to a low of -$332878.0 in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 529,907.00 |
| Aug 31, 2025 | -332,878.00 |
| Nov 30, 2024 | 213,186.00 |
| Aug 31, 2024 | 188,022.00 |
| Jun 30, 2020 | 307,270.00 |
| Dec 31, 2019 | 554,791.00 |
| Dec 31, 2018 | 398,899.00 |
| Dec 31, 2017 | -2.56 Mn |